AmeriJet International has made this announcement:
Air cargo continues to play a key role in the distribution of life-saving vaccines around the world. Amerijet delivered Covid-19 vaccines to the Caribbean and Central America on behalf of Odyssey Logistics Pvt. Ltd. These shipments were a part of India’s Government gifted Covishield AstraZeneca vaccines manufactured by the Serum Institute of India.
The vaccines bound for Jamaica, Guyana, and Nicaragua, were transferred via Amerijet’s Hub at the Miami International Airport. The flagship Amerijet 360,000 square-foot (33,500 sq. meter) facility is one of the most modern at the airport, and includes a 40,000 square-feet (3,700sq. meter) temperature-controlled handling center designed to maintain the cold-chain integrity for refrigerated, frozen, and chilled products. The facility boasts exclusive airside ramp access to the Amerijet fleet for immediate loading and unloading of temperature-controlled shipments. Moreover, an environmentally-protected exclusive pre-cooling receiving area allows for the successful tender, transfer, and transport of vaccines.
Amerijet’s cold-chain pharma standards and processes have been certified by IATA since 2017. The airline completed its preparations to support the Covid-19 vaccine shipments by being the first U.S cargo carrier re-certified under the IATA CEIV program in August 2020.
The company’s investments in climate-controlled infrastructure, training and partnerships with like-minded suppliers underscores Amerijet’s vision to move the goods that enrich and connect the lives of our friends, customers and communities.
Amerijet operates its dedicated freighter fleet of Boeing 767 aircraft throughout the United States, Caribbean, Mexico, Central and South America, and Western Europe. The company provides its service region with more than 8,250 dedicated freighter flights annually. In addition to scheduled service flights, Amerijet offers worldwide long-and short‐term ACMI, CMI and full‐service charters.